These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20587326)

  • 1. [Statins in chronic liver diseases: safety and effect].
    Li GM; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):478-80. PubMed ID: 20587326
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins in liver disease: a molehill, an iceberg, or neither?
    Argo CK; Loria P; Caldwell SH; Lonardo A
    Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins: to use or not to use with elevated LFTs?
    Gillies TJ
    S D Med; 2011 Apr; 64(4):133-4. PubMed ID: 21560996
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and hepatotoxicity: focus on patients with fatty liver.
    Chalasani N
    Hepatology; 2005 Apr; 41(4):690-5. PubMed ID: 15789367
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study.
    Ekstedt M; Franzén LE; Mathiesen UL; Holmqvist M; Bodemar G; Kechagias S
    J Hepatol; 2007 Jul; 47(1):135-41. PubMed ID: 17400325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. Can patients with steatohepatitis take statins?
    Congdon D; St Anna L; Oh RC
    J Fam Pract; 2006 Oct; 55(10):905-6. PubMed ID: 17014759
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid-lowering treatment and liver dysfunction].
    Gencer B; Moradpour D; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):507-8, 510-2. PubMed ID: 22471112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pearls in gastroenterology.
    Henderson PK; Litin SC; Bundrick JB
    Dis Mon; 2018 Aug; 64(8):361-369. PubMed ID: 29880266
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for the use of statins in liver disease.
    Schierwagen R; Uschner FE; Magdaleno F; Klein S; Trebicka J
    Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G407-G412. PubMed ID: 28280144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bile acid therapy; new hope for patients with chronic liver diseases].
    van Berge Henegouwen GP; van Erpecum KJ
    Ned Tijdschr Geneeskd; 1991 Apr; 135(16):696-700. PubMed ID: 2038392
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of statin safety by hepatologists.
    Cohen DE; Anania FA; Chalasani N;
    Am J Cardiol; 2006 Apr; 97(8A):77C-81C. PubMed ID: 16581333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk.
    Riley P; Al Bakir M; O'Donohue J; Crook M
    Cardiovasc Ther; 2009; 27(3):216-20. PubMed ID: 19555426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and hepatitis C virus: friend or foe?
    Emanuele E
    Hepatology; 2010 Jan; 51(1):352. PubMed ID: 19603497
    [No Abstract]   [Full Text] [Related]  

  • 20. Declining frequency of liver enzyme abnormalities with statins: experience from general practice in Jerusalem.
    Kiderman A; Ben-Dov IZ; Glikberg F; Ackerman Z
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1002-5. PubMed ID: 18787468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.